Hester Biosciences Limited - Company Profile

Q: Who are the current directors of Hester Biosciences Limited?

The current directors of Hester Biosciences Limited are Jatin Yagneshbhai Trivedi, Sandhya Maulik Patel, Ravin Kanti Gandhi, Ameetkumar Hiranyakumar Desai, Sanjiv Dinesh Gandhi, Nina Rajiv Gandhi, Bhupendra Vithaldas Gandhi, Rajiv Dinesh Gandhi, Ashok Bhadakal Bhimarao, Anilkumar Mithalal Jain, Vinodkumar Rameshkumar Mali, Priya Rajiv Gandhi, Ashish Dinesh Desai.

It is a pharma public limited company based in Mahesana, Gujarat, India, established in 1987.

1987 Mahesana, Gujarat, India Active

Last Updated: January 28, 2026

Access Report

About Hester Biosciences Limited

Hester Biosciences Limited, a active public limited company, was established on 29 April 1987 in Mahesana, Gujarat, India. Engaging in animal pharmaceuticals & healthcare within the manufacturing sector, it holds CIN: L99999GJ1987PLC022333. Registered under ROC Roc Ahmedabad. it is listed on BSE: 524669 and NSE: HESTERBIO. It has an authorized capital of ₹11.20 Cr and a paid-up capital of ₹8.51 Cr.

Formerly known as Hester Pharmaceuticals Limited, Hester Pharmaceuticals Private Limited. It upholds a compliant status. In 2025, it reported revenue of ₹291.23 Cr and a net worth of ₹339.09 Cr. Employing 695 professional, Its leadership includes Jatin Yagneshbhai Trivedi (Director), Sandhya Maulik Patel (Director), Ravin Kanti Gandhi (Director). Past directors included Jatin Yagneshbhai Trivedi, Sandhya Maulik Patel, Naman Madhav Patel. It holds ₹202.05 Cr open charges and ₹90.09 Cr settled loans. Its latest AGM occurred on 13 August 2025, with the balance sheet filed on 31 March 2025. It is based at Village Meda-Adraj, Taluka Kadi, Mahesana, Gujarat, 384441.

Company Details

CIN/LLPIN
L99999GJ1987PLC022333
Registration Number
022333
Incorporation Date
29 April 1987
Authorized Capital
₹11.20 Cr
Paid-Up Capital
₹8.51 Cr
ROC Code
Roc Ahmedabad
Listing Status
Listed (BSE: 524669, NSE: HESTERBIO)
Company Status
Active

Key Metrics

Authorised Capital ₹ 11.20 Cr as on 28-01-2026
Paid Up Capital ₹ 8.51 Cr as on 28-01-2026
Company Age 38 Year, 9 Months
Last Filing with ROC 31 Mar 2025
Open Charges ₹ 202.05 Cr as on 28-01-2026
Satisfied Charges ₹ 90.09 Cr as on 28-01-2026
Revenue Growth **** 0.63% (FY 2025)
Profit Growth **** 17.24% (FY 2025)
Ebitda **** 7.61% (FY 2025)
Net Worth 8.43% (FY 2025)
Total Assets -0.65% (FY 2025)

Comprehensive Company Insights

Explore comprehensive insights into Hester Biosciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Hester Biosciences Limited?

Current Directors

Name	Designation	Appointment Date	Status
Jatin Yagneshbhai Trivedi	Director	26 Jun 2023	Current
Sandhya Maulik Patel	Director	01 Apr 2020	Current
Ravin Kanti Gandhi	Director	22 Apr 1999	Current
Ameetkumar Hiranyakumar Desai	Director	28 Oct 2021	Current
Sanjiv Dinesh Gandhi	Director	29 Apr 1987	Current
Nina Rajiv Gandhi	Alternate Director	07 May 2016	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Additional Director	19 Sep 2023	Past
Pramod Abcsdd	Additional Director	04 Sep 2020	Past
Pramod Abcsdd	Additional Director	15 Sep 2015	Past
Pramod Abcsdd	Director	21 Jan 2008	Past
Pramod Abcsdd	Director	12 Sep 2013	Past
Pramod Abcsdd	Alternate Director	21 Jan 2008	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Hester Biosciences.

Hester Biosciences Limited, for the financial year ended 2025, experienced modest growth in revenue, with a 0.63% increase. The company also saw a substantial improvement in profitability, with a 17.24% increase in profit. The company's net worth moved up by a moderate rise of 8.43%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

0.63%

*******

Revenue from Operations

*******

0.46%

*******

Total Assets

*******

-0.65%

*******

Profit or Loss

*******

17.24%

*******

Net Worth

*******

8.43%

*******

EBITDA

*******

7.61%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Hester Biosciences?

In 2024, Hester Biosciences had a promoter holding of 53.73% and a public holding of 46.26%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹2,020,482,000.00

Satisfied Charges

₹900,934,500.00

Charges Breakdown by Lending Institutions

State Bank Of India : 202.05 Cr

Latest Charge Details

Date	Lender	Amount	Status
18 Dec 2021	State Bank Of India	₹91.08 Cr	Open
28 Dec 2013	State Bank Of India	₹110.97 Cr	Open
15 Apr 2020	State Bank Of India	₹5.00 Cr	Satisfied
16 Oct 2019	Hdfc Bank Limited	₹3.77 M	Satisfied
26 Jul 2019	Axis Bank Limited	₹5.53 M	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Hester Biosciences?

Hester Biosciences has a workforce of 695 employees as of Sep 23, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Hester Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hester Biosciences's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Hester Biosciences

Recent Activity within the Organization

Director Appointment

Progress on Ashish Dinesh Desai was appointed as a Cfo was appointed as a Cfo on 20 Nov 2025 & has been associated with this company since 2 months 28 days . was documented.
20 Nov 2025
Annual General Meeting

The activity Hester Biosciences Limited last Annual general meeting of members was held on 13 Aug 2025 as per latest MCA records. was completed.
13 Aug 2025
Balance Sheet

The activity Hester Biosciences Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was completed.
31 Mar 2025
Charges

The activity A charge registered on 26 Jul 2019 via Charge ID 100280285 with Axis Bank Limited was fully satisfied on 11 Jul 2024. was completed.
11 Jul 2024
Director Appointment

Progress on Jatin Yagneshbhai Trivedi was appointed as a Director was appointed as a Director on 26 Jun 2023 & has been associated with this company since 2 years 7 months . was documented.
26 Jun 2023
Director Appointment

Anilkumar Mithalal Jain was appointed as a Director was appointed as a Director on 26 Jun 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
26 Jun 2023

Explore recent activity and updates - View Recent Activity